FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019158204> ?p ?o ?g. }

• W2019158204 endingPage "712" @default.
• W2019158204 startingPage "705" @default.
• W2019158204 abstract "Objectives. Development of targeted therapeutics for ovarian cancer requires a basic understanding of ovarian epithelial carcinoma cell biology. The role of estrogen and epidermal growth factor (EGF) in control of cell growth was investigated in a panel of ovarian carcinoma lines. Methods. EGF receptor (EGFR) was detected by flow cytometry and estrogen receptor (ER) by Northern blot. Western blotting and [3H]thymidine incorporation were used to determine receptor activation and the effects of ligand exposure and growth factor antagonists, including the antineoplastic agent, suramin, on cell growth. Results. Only one cell line, OV266, expressed ER and responded to β-estradiol with increases in DNA synthesis and cell proliferation that could be blocked by the pure antiestrogen ICI 182,780. All cell lines possessed functional EGFR as measured by flow cytometry and phosphorylation of the receptor and mitogen-activated protein kinase after EGF treatment, but only two cell lines (OV177 and OV266) proliferated in response to exogenous EGF. Suramin had limited effectiveness in inhibiting growth in four of five cell lines and had a striking dose-dependent stimulatory effect on OV266 cell growth. The proliferative response to suramin could be inhibited with EGFR antagonists. Conclusion. Cultured epithelial ovarian carcinoma cell lines express EGFR (5/5) and can express ER (1/5). Differential growth responses to EGF were observed despite uniform receptor and MAPK activation. Unexpectedly, the antineoplastic agent suramin increased growth of ER positive ovarian carcinoma cells in an EGFR-dependent manner. These studies provide insight into the complex interactions of these systems in control of ovarian cancer cell growth." @default.
• W2019158204 created "2016-06-24" @default.
• W2019158204 creator A5038129767 @default.
• W2019158204 creator A5051439803 @default.
• W2019158204 creator A5062758006 @default.
• W2019158204 creator A5065524254 @default.
• W2019158204 date "2004-09-01" @default.
• W2019158204 modified "2023-09-27" @default.
• W2019158204 title "Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer" @default.
• W2019158204 cites W1544233257 @default.
• W2019158204 cites W1967642037 @default.
• W2019158204 cites W1969870046 @default.
• W2019158204 cites W1970113718 @default.
• W2019158204 cites W1970930172 @default.
• W2019158204 cites W1971331746 @default.
• W2019158204 cites W1983432664 @default.
• W2019158204 cites W1984594456 @default.
• W2019158204 cites W1988557714 @default.
• W2019158204 cites W1991038291 @default.
• W2019158204 cites W1999412153 @default.
• W2019158204 cites W2002497828 @default.
• W2019158204 cites W2003418168 @default.
• W2019158204 cites W2009251966 @default.
• W2019158204 cites W2023242605 @default.
• W2019158204 cites W2028145119 @default.
• W2019158204 cites W2035581814 @default.
• W2019158204 cites W2036614083 @default.
• W2019158204 cites W2039633811 @default.
• W2019158204 cites W2044573147 @default.
• W2019158204 cites W2062051005 @default.
• W2019158204 cites W2063812345 @default.
• W2019158204 cites W2064047613 @default.
• W2019158204 cites W2093676604 @default.
• W2019158204 cites W2104763359 @default.
• W2019158204 cites W2105700959 @default.
• W2019158204 cites W2137849078 @default.
• W2019158204 cites W2145635871 @default.
• W2019158204 cites W2148011209 @default.
• W2019158204 cites W2155510257 @default.
• W2019158204 cites W2167088546 @default.
• W2019158204 cites W2268926393 @default.
• W2019158204 cites W2271214418 @default.
• W2019158204 cites W4235295607 @default.
• W2019158204 cites W4236886267 @default.
• W2019158204 cites W4240942693 @default.
• W2019158204 cites W4243605909 @default.
• W2019158204 cites W4250431719 @default.
• W2019158204 cites W4256194076 @default.
• W2019158204 doi "https://doi.org/10.1016/j.ygyno.2004.05.059" @default.
• W2019158204 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15350362" @default.
• W2019158204 hasPublicationYear "2004" @default.
• W2019158204 type Work @default.
• W2019158204 sameAs 2019158204 @default.
• W2019158204 citedByCount "13" @default.
• W2019158204 countsByYear W20191582042013 @default.
• W2019158204 countsByYear W20191582042014 @default.
• W2019158204 countsByYear W20191582042015 @default.
• W2019158204 countsByYear W20191582042017 @default.
• W2019158204 countsByYear W20191582042018 @default.
• W2019158204 crossrefType "journal-article" @default.
• W2019158204 hasAuthorship W2019158204A5038129767 @default.
• W2019158204 hasAuthorship W2019158204A5051439803 @default.
• W2019158204 hasAuthorship W2019158204A5062758006 @default.
• W2019158204 hasAuthorship W2019158204A5065524254 @default.
• W2019158204 hasConcept C121608353 @default.
• W2019158204 hasConcept C126322002 @default.
• W2019158204 hasConcept C134018914 @default.
• W2019158204 hasConcept C170493617 @default.
• W2019158204 hasConcept C2775960820 @default.
• W2019158204 hasConcept C2776182878 @default.
• W2019158204 hasConcept C2776362946 @default.
• W2019158204 hasConcept C2779438470 @default.
• W2019158204 hasConcept C2780427987 @default.
• W2019158204 hasConcept C3019054536 @default.
• W2019158204 hasConcept C502942594 @default.
• W2019158204 hasConcept C530470458 @default.
• W2019158204 hasConcept C54355233 @default.
• W2019158204 hasConcept C55493867 @default.
• W2019158204 hasConcept C62112901 @default.
• W2019158204 hasConcept C71924100 @default.
• W2019158204 hasConcept C81885089 @default.
• W2019158204 hasConcept C84606932 @default.
• W2019158204 hasConcept C86803240 @default.
• W2019158204 hasConceptScore W2019158204C121608353 @default.
• W2019158204 hasConceptScore W2019158204C126322002 @default.
• W2019158204 hasConceptScore W2019158204C134018914 @default.
• W2019158204 hasConceptScore W2019158204C170493617 @default.
• W2019158204 hasConceptScore W2019158204C2775960820 @default.
• W2019158204 hasConceptScore W2019158204C2776182878 @default.
• W2019158204 hasConceptScore W2019158204C2776362946 @default.
• W2019158204 hasConceptScore W2019158204C2779438470 @default.
• W2019158204 hasConceptScore W2019158204C2780427987 @default.
• W2019158204 hasConceptScore W2019158204C3019054536 @default.
• W2019158204 hasConceptScore W2019158204C502942594 @default.
• W2019158204 hasConceptScore W2019158204C530470458 @default.
• W2019158204 hasConceptScore W2019158204C54355233 @default.
• W2019158204 hasConceptScore W2019158204C55493867 @default.
• W2019158204 hasConceptScore W2019158204C62112901 @default.

• next